Two-Step Method Identifies Active Cullin-RING Ligases

Researchers at the Max Planck Institute of Biochemistry and the University of Waterloo have developed a method to detect which Cullin-RING Ligases (CRLs) are active in cells, shedding light on their role in adapting to various cellular conditions and potentially aiding the development of targeted therapies.

CRLs, a group of over 300 molecular machines, are responsible for tagging proteins for destruction when they are no longer needed or become toxic. Understanding which CRLs are active in response to specific cellular conditions has been challenging. However, this research has developed a two-step method to identify active CRLs.

The first step involves a synthetic antibody that recognizes CRLs attached to the protein NEDD8, a signal for CRL activation. This antibody acts as a "molecular radar" to detect active CRLs. The second step involves mass spectrometry to measure the active CRLs in cells under normal and changing cellular conditions.

The study, published in Nature Chemical Biology, found that certain CRLs are activated in response to iron levels, inflammation signals, and the action of "degrader" drugs used in cancer treatment. The availability of specific CRLs varies between cell types, influencing the effectiveness of degrader drugs.

Additionally, the research revealed differences in active CRLs between macrophages specialized for fighting bacteria and those specialized for wound healing, providing insights into their distinct functions in the immune system.

These findings offer a deeper understanding of how CRLs contribute to dynamic changes in protein balance and their role in pathophysiological states, with potential implications for the development of new therapies.